Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
ANDREOTTI, F.
6817  Ergebnisse:
Personensuche X
?
1

Clinical epidemiology and costs of type 2 diabetic patients..:

Maggioni, A P ; Dondi, L ; Andreotti, F...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
2

From angiotensin-converting enzyme 2 disruption to thromboi..:

Vinci, R. ; Pedicino, D. ; Andreotti, F....
International Journal of Cardiology.  326 (2021)  - p. 243-247 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and safety of dual pathway inhibition in patients ..:

Galli, M ; Capodanno, D ; D'Amario, D...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
4

P4011Efficacy and safety of perioperative aspirin therapy i..:

Wolff, G. ; Navarese, E.P. ; Brockmeyer, M....
European Heart Journal.  38 (2017)  suppl_1 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
5

ANMCO/SICI-GISE paper on antiplatelet therapy in acute coro..:

De Luca, L. ; Bolognese, L. ; Valgimigli, M....
European Heart Journal Supplements.  16 (2014)  suppl C - p. C2-C28 , 2014
Link: https://doi.org/10.1093/..
 
?
6

Corrigendum to: '2013 ESC guidelines on the management of s..:

Montalescot, G. ; Sechtem, U. ; Achenbach, S....
European Heart Journal.  35 (2014)  33 - p. 2260-2261 , 2014
Link: https://doi.org/10.1093/..
 
?
7

Optimal timing of coronary invasive strategy in non-st elev..:

Navarese, E. P. ; Andreotti, F. ; Gurbel, P. A....
European Heart Journal.  34 (2013)  suppl 1 - p. P417-P417 , 2013
Link: https://doi.org/10.1093/..
 
?
8

Expert position paper on the use of proton pump inhibitors ..:

Agewall, Stefan ; Cattaneo, M. ; Collet, J.P....
European Heart Journal.  34 (2013)  23 - p. 1708-1713 , 2013
Link: https://doi.org/10.1093/..
 
?
9

Early vs. delayed invasive strategy in patients with acute ..:

Navarese, E. P. ; De Servi, S. ; Michael Gibson, C....
QJM.  104 (2011)  3 - p. 193-200 , 2011
Link: https://doi.org/10.1093/..
 
?
10

Bleeding risk assessment and management in atrial fibrillat..:

Lip, G. Y. H. ; Andreotti, F. ; Fauchier, L....
Europace.  13 (2011)  5 - p. 723-746 , 2011
Link: https://doi.org/10.1093/..
 
?
11

Low-molecular-weight heparins vs. unfractionated heparin in..:

NAVARESE, E. P. ; DE LUCA, G. ; CASTRIOTA, F....
Journal of Thrombosis and Haemostasis.  9 (2011)  10 - p. 1902-1915 , 2011
Link: https://doi.org/10.1111/..
 
?
12

Bleeding in acute coronary syndromes and percutaneous coron..:

Steg, P. G. ; Huber, K. ; Andreotti, F....
European Heart Journal.  32 (2011)  15 - p. 1854-1864 , 2011
Link: https://doi.org/10.1093/..
 
?
13

32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROT..:

Chapman, M.J. ; Ginsberg, H.N. ; Amarenco, P....
Atherosclerosis Supplements.  12 (2011)  1 - p. 7 , 2011
Link: https://doi.org/10.1016/..
 
?
14

Antithrombotic management of atrial fibrillation patients p..:

Lip, G. Y. H. ; Huber, K. ; Andreotti, F....
European Heart Journal.  31 (2010)  11 - p. 1311-1318 , 2010
Link: https://doi.org/10.1093/..
 
?
15

The unstable plaque: a broken balance:

Crea, F. ; Andreotti, F.
European Heart Journal.  30 (2009)  15 - p. 1821-1823 , 2009
Link: https://doi.org/10.1093/..
 
1-15